admission date:  [2133-8-13]              discharge date:   [2133-9-10]date of birth:  [2069-3-21]             sex:   mservice: medicineallergies:patient recorded as having no known allergies to drugsattending:[first name3 (lf) 7934]chief complaint:weakness, increased abdominal girth,major surgical or invasive procedure:1. tracheostomy placement2. peg tube placementhistory of present illness:pt is a 64 yo m with h/o dm2, cad s/p recent hospitalization forrhabdomyolyis and myopathy presenting with weakness. pt statesthat since d/c on [8-9] he has experienced progressivelyworsening weakness. he states that he has the most difficultygetting out of chair, changing clothes, not as much weakness atthe wrists or ankle. no diplopia or blurry vision, no dysphagia,no headache or jaw pain. pt denies any myalgias, noparaesthesis. on the previous hospitalization his cholesterollowering agents were discontinued as it was thought that thesecould be the possible culprits for rhabdomyolysis. during thathospitalization neurology was consulted, and work up included nltsh, elevated esr, negative [doctor first name ]. pt's health has beendeteriorating over the past year in the setting of a chronicpost surgical would infection at the left foot requiring mostrecently vancomycin. he was started on zyvox 4 days prior tothis presentation. of note, during his prior hospitalization hecomplained of sob and had an oxygen requirement. echodemonstrated an ef of % and it was felt that he possibly haddiastolic heart failure. he responded to gentle diuresis withsubjective improvement in symptoms. pulmonary was consulted atthat time and recommended outpt sleep study. his hospital courseresults were also remarkable for persistently elevated lfts. anmri was planned to further evaluate but pt was unable to fit inmri due to abdominal girth..in the ed his labs were notable for elevated ck to < [numeric identifier 4731]. thiswas higher than the ck max at the prior hospitalization. he wasgiven 1l ns..ros: positive for mild sob which he says is unchanged sincedischarge - overall improved over the past month since startingdiuretics; denies cp/palp/cough/diarrhea/rash.past medical history:iddm, htn, afib w/ anticoagulation therapygout, hypercholesterolemia, arthritiscadpsh:s/p l 5th  ray amputation [2130]s/p r inguinal hernia repair [2128]s/p cholecystectomys/p coronary artery by pass surgery x4 [2127]s/p l tma [12/2131]social history:retired postal worker, married, 4 children, no tobacco, no drugsuse, etoh qweek, wife involvedfamily history:mother died of liver cancer in her 70'sphysical exam:vs: 130/80, hr 87, rr 16, 89% ra, 96% 2l oxygengen - nadheent - perrl, extraocular motions intact, anicteric, mucousmembranes moistneck - jvp 8cm, no cervical lymphadenopathychest - cta blcv - irrg/irreg nl s1 s2 no mrgabd - obese, nt, nd, nabsback - no costovertebral angle tendernes, no sacral edemaextr - no clubbing, cyanosis, 1+ edema to mid shin blleft - foot surgical scar woundneuro - alert and oriented x 3, cranial nerves [3-8] intact, uestrength 5/5 except for deltoid ([4-29]), le [5-29] except for hipextensors ([4-29]); sensation intactskin - no rashpertinent results:[2133-8-13] 05:30pm   glucose-120 urea n-43 creat-1.4 sodium-138potassium-4.2 chloride-100 total co2-28 anion gap-14[2133-8-13] 05:42pm   lactate-1.5[2133-8-13] 05:30pm   alt(sgpt)-542 ast(sgot)-573 ck(cpk)-[numeric identifier 37476]alk phos-63 tot bili-0.5[2133-8-13] 05:30pm   lipase-39[2133-8-13] 05:30pm   wbc-8.5 rbc-4.15 hgb-12.3 hct-35.8 mcv-86mch-29.6 mchc-34.4 rdw-16.4[2133-8-13] 05:30pm   neuts-79.3 lymphs-14.2 monos-4.6 eos-1.6basos-0.4[2133-8-13] 05:30pm   anisocyt-1+ microcyt-1+[2133-8-13] 05:30pm   plt count-192.cxr--bibasilar atelectasis, cardiomegaly..final diagnosis:right deltoid muscle biopsy (including snap-frozen tissue):acute, recent, and chronic myopathy (chronic active myopathy)acute myofiber necrosis.scattered degenerating and regenerating myofibers and scatteredmyophagocytosis, indicative of recent myofiber injury.increased endomysial connective tissue, increased frequency ofinternalized nuclei, and scattered split myofibers, indicativeof chronic myopathy.scattered cd4 and cd8 t-lymphocytes, without direct associationwith pathologic changes.coarse lipid and mitochondrial staining in degeneratingmyofibers.note:in addition to the findings identified in the preliminaryreport, these special stains identify coarse lipid staining inmany of the degenerating myofibers, along with correspondingchanges in mitochondria. while not specific, they are consistentwith a metabolic myopathy affecting lipid metabolism, as can beinduced by toxic agents and several drugs. they are consistentwith effects of some cholesterol lower agents, especiallycombinations of agents in elderly patients. diagnostic changesof an inflammatory myositis are not identified in this biopsy.microscopic description:h&e stain: increased internalized nuclei and split myofibers;scattered myophagocytosis and frequent degenerating andregenerating myofibers, including atrophic basophilic fibers;moderate to marked variation in myofiber size; frequent small,round or angulated myofibers; scattered acutely necroticmyofibers having pale eosinophilic staininggomori trichrome stain: increased endomysial connective tissuein sites of greatest degeneration; no ragged red fibers;degenerating myofibers often show coarse staining ofsarcoplasmic mitochondriapas stain: normal distribution of glycogenpas + diastase stain: no diastase-resistant glycogenoil red "o" stain: coarse staining of degenerating myofibersnadh histochemistry: coarse staining of degenerating myofibersin a mitochondrial pattern (mitochondrial clumping)atpase (ph 4.3, 4.6, 9.5) histochemistry: type i myofiberpredominant; atrophic myofibers of both types - predominantlytype ii; no diagnostic type grouping.cd3 immunoperoxidase: non-contributorycd4 immunoperoxidase: scattered t4 lymphocytes throughoutspecimen; not directly associated with individual myofiberinjurycd8 immunoperoxidase: scattered t8 lymphocytes throughoutspecimen; not directly associated with individual myofiberinjurycd68 immunoperoxidase: non-contributoryfactor viii immunoperoxidase: normal numbers of vessels,including endomysial capillariesbrief hospital course:a/p:64yo man with h/o tiidm, cad, afib, and gout, presenting  withmyositis vs rhabdomyalysis, transferred now with tachypnea andhypercapnia and acidemia..#  respiratory failure  poor ventilation due to progressivemuscle weakness.  rising pco2 and respiratory acidemiaprogressed to hypercarbic respiratory failure.  no evidence ofprimary pulmonary process.-  pt intubated for worsening ventilation/oxygenation in settingof worsening weakness-  remained intubated due to poor nifs.  very brief sbt failedwhen pt had no respiratory effort.-given continued poor respiratory muscle strength, likelihood oflengthy intubation, percutaneous tracheostomy performed on[2133-9-1] and trach placed.  complicated trach placement due tosubcutaneous emphysema on same day of trach placement.  incisionsite was widened and subcutaneous emphysema and swellingdecreased over the next two days.  no pneumothorax orpneumomediastinum seen on cxr..#  myospathy:  rhabdomyolysis/myopathy, pathololgy from musclebiopsy suggests myopathic changes, possibly drug-induced.rheumatology and neurology consulted.  not thought that steroidswill help this disease process.  off statins, will follow ck andclinical picture, await gradual recovery..#  arf:  contrast nephropathy, atn on chronic diabeticnephrophathy.  patient briefly anuric.  hemodialyzed, but nowwith improving renal function, increased urine output, nofurther need for dialysis at this time..#  transaminitis:  lfts returned to nl; likely due to rhabdo.hepatitis serologies negative.  cta abdomen nondiagnostic.#  foot wound:  patient completed 10days linezolid per podiatryrecc's.  podiatry following..#  tiidm: riss + nph for elevated blood sugars..#  htn:  metoprolol.#  fen:  diabetic, cardiac diet; peg placed on [9-8].#  ppx:  sc heparin, po diet.#  access:  picc.#  full codemedications on admission:allopurinol 200 mg po dailyaspirin 81 mg po dailyclonidine 0.3 mg/24 hr patch weekly qsatirbesartan 300 mg po qdwarfarin 5 mg po 6x/week (mo,tu,we,th,fr,sa)docusate sodium 100 mg po bidomega-3 fatty acids 550 mg po bidgabapentin 300 mg po bidfolic acid 1 mg po dailycyanocobalamin 1,000 mcg/ml for 7 days.furosemide 40 mg po dailymetoprolol tartrate 50 mg po bidinsulin nph-regulardischarge medications:1. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewablepo daily (daily).2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2times a day) as needed.3. folic acid 1 mg tablet sig: one (1) tablet po daily (daily).4. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2)tablet, delayed release (e.c.) po daily (daily) as needed.5. gabapentin 100 mg capsule sig: two (2) capsule po daily(daily).6. allopurinol 100 mg tablet sig: one (1) tablet po every otherday (every other day).7. heparin (porcine) 5,000 unit/ml solution sig: one (1)injection tid (3 times a day).8. miconazole nitrate 2 % powder sig: one (1) appl topical  qid(4 times a day) as needed.9. lansoprazole 30 mg susp,delayed release for recon sig: one(1)  po daily (daily).10. acetylcysteine 20 % (200 mg/ml) solution sig: one (1) mlmiscell.  q4-6h (every 4 to 6 hours) as needed.11. olanzapine 5 mg tablet sig: one (1) tablet po daily (daily).12. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalationq6h (every 6 hours) as needed.13. ipratropium bromide 17 mcg/actuation aerosol sig: two (2)puff inhalation q4-6h (every 4 to 6 hours) as needed.14. citalopram 20 mg tablet sig: one (1) tablet po daily(daily).15. warfarin 5 mg tablet sig: one (1) tablet po hs (at bedtime).16. metoprolol tartrate 50 mg tablet sig: two (2) tablet po tid(3 times a day).17. hydralazine 20 mg/ml solution sig: one (1)  injection q6h(every 6 hours) as needed for sbp>155.18. vancomycin hcl 1000 mg iv q 12hdischarge disposition:extended carefacility:[hospital3 7] & rehab center - [hospital1 8]discharge diagnosis:1. myopathy2. respiratory failuredischarge condition:gooddischarge instructions:- please take all medications as prescribed.- return if you have any worsening weakness, any worseningmuscle cramping, chest pain, dizziness, faintness, or any otherconcerning symptoms.followup instructions:please follow up with your primary care physician [name initial (pre) 176] 1 weekof discharge.